BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
BTX.WS was delisted on the 26th of September, 2018.
37 hedge funds and large institutions have $1.55M invested in BioTime Inc Warrants (Expiring October 1, 2018) in 2014 Q4 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.11M |
| 2 |
First Eagle Investment Management
New York
|
+$196K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$139K |
| 4 |
PCA
Private Capital Advisors
Darien,
Connecticut
|
+$78.4K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$22.2K |
Top Sellers
BTX.WS Hedge Fund Activity: Q4 2014 in Review
37 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) for Q4 2014, worth a combined $1.55M.
Buyers outnumbered sellers: 37 funds opened new BTX.WS positions and 0 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Deutsche Bank, opening a new position worth an estimated $1.11M.
- 37 institutional investors held BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) as of Q4 2014, up from 0 in Q3 2014.
- Funds reported $1.55M of BioTime Inc Warrants (Expiring October 1, 2018) stock for Q4 2014.
- 37 funds opened new BioTime Inc Warrants (Expiring October 1, 2018) positions in Q4 2014 and 0 closed out, a net change of +37 holders.
- The largest BioTime Inc Warrants (Expiring October 1, 2018) buyer in Q4 2014 was Deutsche Bank, an estimated $1.11M added.
Based on aggregated 13F filings for Q4 2014.